ColonaryConcepts begins Phase Ib trial of edible bar delivering laxative ingredient to treat CIC

US-based biotech firm ColonaryConcepts has initiated the Phase Ib Chronic Constipation trial of C-bar, delivering PEG-3350 to treat chronic idiopathic constipation (CIC).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news